Literature DB >> 28673727

Central serous chorioretinopathy and glucocorticoids: an update on evidence for association.

Benjamin P Nicholson1, Elizabeth Atchison1, Amrou Ali Idris1, Sophie J Bakri2.   

Abstract

Central serous chorioretinopathy is a common idiopathic retinal disease characterized by central vision loss from serous detachment of the neurosensory retina, serous pigment epithelial detachments, and leakage of fluid through the retinal pigment epithelium into the subretinal space. The concept of an association between exogenous glucocorticoid use and central serous chorioretinopathy is widely accepted among ophthalmologists. Here, we review the evidence for and against such an association. This evidence includes 2 large, case-control studies that found strong associations, and a smaller, population-based study that found no association. We conclude that the preponderance of the literature on this topic supports the existence of an association. Both exogenous and endogenous glucocorticoids have been implicated. Although a mechanism and a causal relationship remain to be established, the association deserves broader recognition among physicians who prescribe glucocorticoids.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  central serous chorioretinopathy; glucocorticoids; joint injections; pregnancy; side effects; steroid; topical steroid; transplantation

Mesh:

Substances:

Year:  2017        PMID: 28673727     DOI: 10.1016/j.survophthal.2017.06.008

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  25 in total

1.  Central serous retinopathy as presentation of an adrenal adenoma.

Authors:  Brijesh Takkar; Shreyas Temkar; Nripen Gaur; Pradeep Venkatesh
Journal:  BMJ Case Rep       Date:  2018-12-14

Review 2.  [Statement and recommendation of the Professional Association of German Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the German Retina Society (RG) on central serous chorioretinopathy : Situation January 2018].

Authors: 
Journal:  Ophthalmologe       Date:  2018-05       Impact factor: 1.059

Review 3.  [Statement of the Professional Association of Ophthalmologists in Germany (BVA), the German Ophthalmological Society (DOG) and the Retinological Society (RG) on central serous chorioretinopathy : Status 18 October 2021].

Authors: 
Journal:  Ophthalmologe       Date:  2021-12-14       Impact factor: 1.059

Review 4.  Statement of the Professional Association of Ophthalmologists in Germany (BVA), the German Society of Ophthalmology (DOG) and the German Retina Society (RG) on central serous chorioretinopathy : Status 18 October 2021.

Authors: 
Journal:  Ophthalmologie       Date:  2022-04-06

5.  Association between endogenous cortisol level and the risk of central serous chorioretinopathy: a Meta-analysis.

Authors:  Zhi-Qiao Liang; Lyu-Zhen Huang; Jin-Feng Qu; Ming-Wei Zhao
Journal:  Int J Ophthalmol       Date:  2018-02-18       Impact factor: 1.779

6.  Central serous chorioretinopathy with and without steroids: A multicenter survey.

Authors:  Takashi Araki; Hiroto Ishikawa; Chiharu Iwahashi; Masanori Niki; Yoshinori Mitamura; Masahiko Sugimoto; Mineo Kondo; Takamasa Kinoshita; Tomo Nishi; Tetsuo Ueda; Aki Kato; Tsutomu Yasukawa; Yoshihiro Takamura; Fumi Gomi
Journal:  PLoS One       Date:  2019-02-28       Impact factor: 3.240

7.  Comment: Clinical profile of uveitis patients developing central serous chorioretinopathy - An experience at a tertiary eye care center in India.

Authors:  Aditya Aseem; Kushagra Jain; Naresh Kumar Yadav; Ramesh Venkatesh
Journal:  Indian J Ophthalmol       Date:  2019-07       Impact factor: 1.848

8.  Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine.

Authors:  Nicholas Fowler; Noe R Mendez Martinez; Bernardo Velazquez Pallares; Ramiro S Maldonado
Journal:  Am J Ophthalmol Case Rep       Date:  2021-06-12

Review 9.  Central Serous Chorioretinopathy and Personality Characteristics: A Systematic Review of Scientific Evidence over the Last 10 Years (2010 to 2020).

Authors:  Giovanni Genovese; Alessandro Meduri; Maria Rosaria Anna Muscatello; Sebastiano Gangemi; Clemente Cedro; Antonio Bruno; Pasquale Aragona; Gianluca Pandolfo
Journal:  Medicina (Kaunas)       Date:  2021-06-16       Impact factor: 2.430

10.  Keratoconus with Central Serous Chorioretinopathy: A Rare Combination.

Authors:  Anastasia Tsiogka; Apostolos Gkartzonikas; Konstantinos Markopoulos; Iordanis Georgiou; George L Spaeth
Journal:  Case Rep Ophthalmol Med       Date:  2020-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.